XALKORI: 535 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

535

Total FAERS Reports

161 (30.1%)

Deaths Reported

Hospitalizations

535

As Primary/Secondary Suspect

Life-Threatening

Disabilities

First Report: 201110 · Latest Report: 20140616

What Are the Most Common XALKORI Side Effects?

#1 Most Reported

Disease progression

125 reports (23.4%)

#2 Most Reported

Death

90 reports (16.8%)

#3 Most Reported

Lung neoplasm malignant

67 reports (12.5%)

Side Effect	Reports	% of Total	Deaths	Hosp.
Disease progression	125	23.4%	53	12
Death	90	16.8%	90	6
Lung neoplasm malignant	67	12.5%	27	8
Nausea	64	12.0%	5	4
Diarrhoea	43	8.0%	0	4
Fatigue	32	6.0%	2	2
Vomiting	29	5.4%	3	6
Constipation	27	5.1%	1	3
Oedema peripheral	27	5.1%	4	2
Off label use	26	4.9%	10	2
Decreased appetite	20	3.7%	1	2
Dizziness	18	3.4%	0	3
Pneumonia	18	3.4%	7	9
Neoplasm malignant	17	3.2%	1	0
Dysgeusia	15	2.8%	0	0
Malaise	14	2.6%	3	4
Non-small cell lung cancer	14	2.6%	11	3
Visual impairment	14	2.6%	1	1
Dyspepsia	13	2.4%	0	3
Interstitial lung disease	12	2.2%	2	8

Average age: 61.7 years. Most reports from: US. View detailed demographics →

Year	Reports	Deaths	Hosp.
2011	2	0	0
2012	14	4	5
2013	74	30	26
2014	128	56	23

Indication	Reports
Lung neoplasm malignant	269
Non-small cell lung cancer	70
Neoplasm malignant	20
Lung cancer metastatic	12
Non-small cell lung cancer metastatic	10
Lung adenocarcinoma	6
Tracheal cancer	5

Official prescribing information from the FDA-approved drug label.